The 12 closest competitors and alternatives to Alchemab Therapeutics among biotechnology companies — ranked by similarity to what Alchemab Therapeutics actually does, not by market-cap band.
Subscribe to see Alchemab Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Alchemab Therapeutics Ltd is a biotechnology company headquartered in London, England, focused on pioneering patient-centric antibody discovery and development.
Alchemab Therapeutics is a biotechnology company headquartered in United Kingdom, founded in 2019. Xcout tracks 4 named people at Alchemab Therapeutics, including Jane Osbourn (Chief Executive Officer). Xcout recorded 1 job posting from Alchemab Therapeutics in the last 90 days.
Xcout recorded 1 job posting from Alchemab Therapeutics in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Alchemab Therapeutics's hiring signals →
Ranked by semantic similarity — how close each company is to Alchemab Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Pheon Therapeutics is a biotechnology research company headquartered in London, England, that specializes in developing next-generation antibody-drug conjugates for hard-to-treat cancers.
Biotech
Numab Therapeutics is a Swiss biotechnology company developing multispecific antibody-based medicines that modulate immune-cell interactions. Its programs target serious diseases including cancer and immune-mediated or inflammatory disorders, serving patients through development and potential partnerships with pharmaceutical companies.
Similar biotechnology company
Adimab is a biotechnology research company headquartered in Lebanon, New Hampshire, that serves as a biopharmaceutical industry partner for therapeutic antibody discovery and engineering.
Life Sciences
Cytospire Therapeutics Limited is a biotechnology research company based in London, United Kingdom. The company is focused on developing a portfolio of next-generation immune cell engagers to improve patients' lives.
Similar biotechnology company
IsomAb is a biotechnology research company headquartered in Nottingham, United Kingdom, focused on developing isoform-specific humanized antibodies to treat cardiovascular and other serious diseases.
Similar biotechnology company
Centauri Therapeutics Limited is a privately held immunotherapy company with its primary headquarters located in London, United Kingdom.
Similar biotechnology company
Star Therapeutics is a biotechnology company that discovers and develops antibody therapies to treat patients with serious diseases. The company focuses on creating patient-centric medical solutions to address real-world healthcare needs.
Similar biotechnology company
AbbraTech Holdings LLC operates a platform technology focused on recombinant antibody discovery, engineering, and validation. The company targets human diseases such as cancer, immune disorders, and viral infections by developing antibodies for difficult-to-reach drug targets through its proprietary Epivolve technology.
Biotech
Infinimmune is an Alameda, California-based biotechnology company founded in 2022 that develops human-derived antibody medicines and holds a massive database of paired heavy and light sequences.
Biotech
AbCellera is a biotechnology company that integrates biology, computation, and engineering to discover and develop antibody-based medicines. The company operates a proprietary technology platform to advance internal and partnered drug programs across therapeutic areas such as endocrinology, immunology, autoimmunity, and oncology.
Biotech
Antiverse is a biotechnology research company headquartered in Cardiff, Wales, that utilizes generative artificial intelligence to design functional antibodies for challenging drug targets.
Biotech
Crossbow Therapeutics is a privately held biotechnology company founded in 2021 and headquartered in Cambridge, Massachusetts. The company develops potent antibody therapeutics aimed at expanding treatment options and combating cancer.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Alchemab Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →